当前位置: 首页 > 医疗版 > 疾病专题 > 精神内科 > 精神分裂症
编号:13529422
齐拉西酮与奥氮平治疗早期精神分裂症的疗效与安全性的相关研究(1)
http://www.100md.com 2019年11月1日 《健康大视野》 201921
     【摘 要】目的:探讨齐拉西酮与奥氮平治疗早期精神分裂症的应用效果。方法:选取2017年1月-2019年3月我院72例早期精神分裂症患者为研究对象,依据患者治疗药物不同分均分为对照组和观察组,对照组选用奥氮平治疗,观察组选用齐拉西酮治疗,对比两组情况。结果:观察组在本次研究中所取得总有效率数值94.44%高于对照组所取得数值80.56%,观察组在本次研究中所取得不良反应发生率数值11.11%低于对照组所取得数值30.56%,统计学有意义(P<0.05)。结论:齐拉西酮治疗早期精神分裂症的应用效果显著,值得应用。

    【关键词】齐拉西酮;早期精神分裂症;奥氮平;应用效果

    Abstract:Objective To investigate the effect of ziprasidone and olanzapine in the treatment of early schizophrenia.METHODS: Seventy-two patients with early schizophrenia in our hospital from January to September 20-19 were enrolled.The patients were divided into the control group and the observation group according to the different treatments.The control group was treated with olanzapine.The ziprasidone treatment was used to compare the two groups.RESULTS: The total effective rate of the observation group in this study was 94.44% higher than that obtained by the control group ......
1 2下一页

您现在查看是摘要页,全文长 3754 字符